Cognitive Symptom
27
4
5
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
1 terminated out of 27 trials
93.8%
+7.2% vs benchmark
4%
1 trials in Phase 3/4
13%
2 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (27)
Can Cranberry Juice Enhance the Cognition Accuracy and Alleviate Negative Mental Consequences During Multitasking?
Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case Repts
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
Using Non-invasive Brain Stimulation to Treat Word Finding Difficulty in Chronic Traumatic Brain Injury
Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)
Cognitive Enhancement in Depression (The COG-D Study)
Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
Chronic Neck Pain and Cognitive Function
Prevention of Long Covid Syndrome
PrimeCog: Primary Care Cognitive Testing
Effect of Extended Cannabis Abstinence on PTSD Symptoms
Food Allergy in the Brain
MBSR During AI Therapy for Breast Cancer
Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM)
Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis
CBCR for Executive Functions in Patients With ABI in the Chronic Phase
The Effect of Transcranial Direct Stimulation on Cognitive Functions of Healthy Adults
The Effects of a Nutrition Supplement on Health Related Quality of Life
Psychotropic Drug Use in the Elderly Living in Nursing Homes and the Influence of a Structured Drug Review
Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease